ARYx Therapeutics Inc (NASDAQ:ARYX) to Hold Q1 2008 Earnings Conference Call May 13

ARYx Therapeutics Inc (NASDAQ:ARYX) will hold a conference call on Tuesday, May 13 at 8:00 am to discuss the first quarter earnings for 2008.  A live webcast of the call will be available at investors.aryx.com/events.cfm.

ARYx Therapeutics, Inc. (ARYx) is a biopharmaceutical company focused on developing a portfolio of potentially safer oral product candidates that retain the efficacy of commercially successful drugs for established chronic markets. The Company employs its RetroMetabolic Drug Design technology to engineer structurally molecules. The process utilizes a series of steps designed to eliminate specific unwanted effects of the original drug.

ARYx's most advanced product candidate is ATI-7505, which has successfully completed Phase 2 clinical trials for the treatment of gastroesophageal reflux disease and symptoms associated with functional dyspepsia. Other potential products in advanced stages of development are ATI-5923 for anticoagulation and ATI-2042 for atrial fibrillation. The Company has several other products in the pipeline.

Find more Earnings events on Finditt Events.

Read more Business News at:

http://news.finditt.com/NewsList.aspx?cat=1&wcat=3